The CIEGE Certificate, promoted by elEconomista.es and Informa D&B, is based on one of the most rigorous evaluations on the market, with more than 50 indicators grouped into 10 key areas.
Farmalider achieved a score of 76%, exceeding the required criteria and ranking more than ten points above the historical average of certified companies, reinforcing its leadership in innovation, responsible management, and sustainability.
A pharmaceutical–biotechnology company specialized in prescription medicines, OTC products, health care solutions, and biotechnological developments, Farmalider operates in more than 80 countries and has filed over 333 patent registrations worldwide.
María Luisa Berenguer Muñoz, CEO of Farmalider, after receiving the 2025 CIEGE Certificate of Excellence in Business Management
Madrid, 1 December 2025. – Farmalider, a Spanish pharmaceutical–biotechnology company specialized in the B2B development and supply of prescription medicines, OTC products, health care solutions, and advanced biotechnological innovations, has been awarded the 2025 CIEGE Certificate of Excellence in Business Management, granted by elEconomista.es and Informa D&B, two leading organizations in economic information and business analysis.
The company achieved a score of 76%, far exceeding the required standards and placing itself more than ten points above the historical average of certified companies. This accomplishment strengthens Farmalider’s commitment to a management model focused on innovation, sustainability, and long-term value creation for its partners and stakeholders.
The recognition was presented on 26 November during the VIII Edition of the CIEGE Gala, held at the Rafael del Pino Auditorium in Madrid.
The CIEGE Certificate recognizes excellence in organizations that successfully complete a rigorous evaluation based on more than 50 indicators across ten key areas: solvency, profitability, growth, employment, internationalisation, corporate social responsibility, customer satisfaction, innovation, commercial risk management, and digitalisation. This comprehensive assessment highlights the company’s strengths, identifies improvement opportunities, and endorses management practices aligned with the highest standards in the market.
Farmalider, represented by its President, José Luis Berenguer Huertas, and its CEO, María Luisa Berenguer Muñoz, received the CIEGE Certificate, which acknowledges the company’s progress toward a responsible, competitive, and internationally oriented business model.
“For a pharmaceutical company like Farmalider, excellence in management is as strategic as the scientific evidence supporting our products,” explains María Luisa Berenguer Muñoz, CEO of Farmalider. “We develop prescription medicines, OTC products, health care solutions, and biotechnological innovations that are now present in more than 80 countries and supported by over 333 patent registrations. This certificate strengthens our position as a leading B2B partner and represents an additional guarantee of robustness and trust for our clients, suppliers, and investors, within a model based on proprietary innovation, a solid industrial network, and a long-term vision.”
Since its launch in 2018, hundreds of Spanish companies have been recognized with this distinction, which has become one of the most respected certifications in the business landscape due to its rigor and its ability to identify strengths and improvement areas, strengthen the confidence of clients and suppliers, and enhance brand recognition and corporate reputation.
https://www.eleconomista.es/galerias/eleconomista/23512/VIII-Edicion-Certificados-CIEGE-II/39
